Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease

American Journal of Gastroenterology

Volumn 92, Issue 7, 1997, Pages 1170-1173

  Hendel, J ^a   Nielsen, O H ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSCOPY; ENTERITIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; ULCERATIVE COLITIS;

ACUTE DISEASE; ADULT; CYCLOOXYGENASE 2; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFLAMMATORY BOWEL DISEASES; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE;

EID: 0030875018     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Nielsen OH, Rask-Madsen J. Mediators of inflammation in chronic inflammatory bowel disease. Scand J Gastroenterol 1996;31(suppl 216):149-59.
2. Davies P, MacIntyre DE. Prostaglandins and inflammation. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic principles and clinical correlates, 2nd ed. New York: Raven Press Ltd., 1992: 123-38.
3. Eberhart CE, Dubois RN. Eicosanoids and the gastrointestinal tract. Gastroenterology 1995;109:285-301.
4. Ham EA, Soderman DD, Zanetti ME, et al. Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils. Proc Natl Acad Sci USA 1983;80:4349-53.
5. 2: Intrvenous, oral, and intrajejunal administration. Gastroenterology 1976;70:359-70.
6. 2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 1986;91:837-44.
7. Rampton DS, McNeil NI, Sarner M. Analgesic ingestion and other factors preceding relapse in ulcerative colitis. Gut 1983;24:187-9.
8. Gould SR, Brash AR, Conolly ME, et al. Studies of prostaglandins and sulphasalazine in ulcerative colitis. Prostaglandins Leukotrienes Med 1981;6:165-82.
9. Rampton DS, Sladen GE. Prostaglandin synthesis inhibitors in ulcerative colitis: Flurbiprofen compared with conventional treatment. Prostaglandins 1981;21:417-25.
10. Simmons DL, Lu X, Bradshaw WS, et al. The dilemma of two cyclooxygenases: identifying the roles of COX-1 and COX-2 in inflammation and apoptosis. In: Vane JR, Botting JH, Bolting RM, eds. Improved non-steroid anti-inflammatory drugs: COX-2 enzyme inhibitors. London: Kluwer Academic Publishers, 1996:45-65.
11. Xie W, Chipman JG, Robertson DL, et al. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88:2692-6.
12. Vane JR, Mitchell JA, Appleton I. Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc Natl Acad Sci USA 1994;91:2046-50.
13. Mitchell JA, Akarasereenont P, Thiemermann C, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993;90:11693-7.
14. Pairet M, Engelhardt G. Differential inhibition of COX-1 and COX-2 in vitro and pharmacological profile in vivo of NSAIDs. In: Vane JR, Botting JH, Botting RM, eds. Improved non-steroid anti-inflammatory drugs. COX-2 enzyme inhibitors. London: Kluwer Academic Publishers, 1996:103-19.
15. Crofford LJ, Wilder RL, Ristimäki AP, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. J Clin Invest 1994;93:1095-101.
16. Langholz E, Munkholm P, Nielsen OH, et al. Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 1991;26:1247-56.
17. Munkholm P, Langholz E, Nielsen OH, et al. Incidence and prevalence of Crohn's disease in the counly of Copenhagen, 1962-1987: A six fold increase in incidence. Scand J Gastroenterol 1992:27:608-14.
18. Binder V. A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis. Scand J Gastroenterol 1970;5: 627-32.
19. Chomczynski P. A reagent for the single step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993;15:532-7.
20. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992;89:7384-8.
21. Ercolani L, Florence B, Denaro M, et al. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 1988;263:15335-41.
22. Hanauer SB. Inflammatory bowel disease. N Engl J Med 1996;334: 841-8.
23. Gagniella TS, Walsh RE. Sulfasalazine: Multiplicity of action. Dig Dis Sci 1992;37:801-12.
24. Hawkey CJ, Rampton DS. Benoxaprofen in the treatment of active ulcerative colitis. Prostaglandins Leukotrienes Med 1983;10:405-9.
25. O'Bannion MK, Sadowski HB, Winn V, et al. A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 1991;266:23261-7.
26. Kujubu DA, Fletcher S, Varnum BC, et al. TIS 10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991;266:12866-72.
27. Vane JR, Botting RM. Overview: Mechanisms of action of antiinflammatory drugs. In: Vane JR, Botting JH, Botting RM, eds. Improved non-steroid anti-inflammatory drugs COX-2 enzyme inhibitors. London: Kluwer Academic Publishers, 1996;1-27.
28. Morita I, Schindler M, Regier MK, et al. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and-2. J Biol Chem 1995;270:10902-8.
29. Morita I, Shitashige M, Murota S. Different substrate utilization between prostaglandin endoperoxide H synthase-1 and -2. Third International World Congress 1996 (abstract).